Follow Best Investments Alerts Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
On Saturday, maybe you're planning to go for a run, watch some cartoons, or make your family a nice breakfast.
For me, I'll be up bright and early, as I am each Saturday, looking for more profit opportunities for you in the tech world. And this Saturday in particular, I'll be checking out the latest initial public offerings (IPOs).
Let me explain…
It's rare that I don't start working by 7:15 a.m. on Saturdays. It's a great time to look at tech trends and screen a host of stocks when there's no noise from the market.
And every Saturday, I try to update my list of new tech stocks.
After spending 34 years in Silicon Valley and serving as a strategic consultant to a dozen startups, tracking IPOs comes naturally to me.
I want to see if any of my "babies" have graduated.
So, I get the names of newly public tech and life sciences stocks and put them on my post-IPO tracking screen. On Saturday, July 7, alone, I had to input 28 new stocks into my online database.
I didn't spend much time doing that in 2017, which was a weak year for IPOs.
But this year, the IPO market is on fire… and my Saturday mornings are busier.
Led by the successful IPOs of tech firms like Dropbox Inc. (Nasdaq: DBX) in March, and Spotify Technology SA (NYSE: SPOT) in April, tech IPOs are up 92% from last year, according to a report in TechCrunch.
This turn of events is crucial for technology investors like us.
Today I'll show you why that is – and I'll show you the best way to play this hot, hot, hot trend…
A Target-Rich Environment
IPOs can be a dicey proposition for the average retail investor.
Typically, in the first six months of trading, these can be very volatile stocks. That can cause some heartburn.
Furthermore, most investors don't have the discipline to put in a lowball limit order to catch IPOs when they dip from their highs in the early days of trading.
[ATTENTION] Are You Owed $23,441 by the U.S. Government? Click Here Now.
But here's the thing – IPOs are vital for a healthy market. And there's no question that they can offer tech investors a target-rich environment.
Plus, the profitable strategy that an IPO represents gives Silicon Valley entrepreneurs a great motivation to start new companies. That, in turn, brings us a steady wave of innovations – and, eventually, stocks to buy.
Now, nothing keeps a bull market moving forward like a group of new stocks to trade. These exciting opportunities have a way of pulling fresh cash into the market.
Fortunately, there is a way to cash in on the tech IPO boom in a way that builds your net worth – and allows you to sleep calmly at night.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.